Stay updated with breaking news from Process Performance Qualification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
15.11.2023 - Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system ...
Operator: Good morning, ladies and gentlemen and welcome to Adaptimmune’s Q2 Financial and Business Update Conference Call. I would now like to turn the meeting call over to Ms. Juli Miller.
Proceeds from $25 million registered direct offering in July allow initiation of pre-commercial launch activities for EB-101 Cash on hand plus proceeds from registered direct...
On track for Biologics License Application (BLA) submission in third quarter of 2023
CLEVELAND, June 09, 2023 -- Abeona Therapeutics Inc. today announced that it received feedback from the U.S. Food and Drug Administration on June 8, 2023, in which the Company gained the... | June 9, 2023